Dhanish Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 31-07-2024
- Paid Up Capital ₹ 3.00 M
as on 31-07-2024
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 20.22%
(FY 2023)
- Profit 343.73%
(FY 2023)
- Ebitda 1553.16%
(FY 2023)
- Net Worth 21.57%
(FY 2023)
- Total Assets 15.16%
(FY 2023)
About Dhanish Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Naik, Vishal Naik, and Deepak Badiyani serve as directors at the Company.
- CIN/LLPIN
U51397WB2009PTC135822
- Company No.
135822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dhanish Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Naik  | Director | 11-Jun-2009 | Current |
| Vishal Naik | Director | 11-Jun-2009 | Current |
| Deepak Badiyani | Director | 04-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Dhanish Pharma Distributors.
Dhanish Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.22% increase. The company also saw a substantial improvement in profitability, with a 343.73% increase in profit. The company's net worth Soared by an impressive increase of 21.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanish Pharma Distributors?
In 2023, Dhanish Pharma Distributors had a promoter holding of 81.67% and a public holding of 18.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishal Fragrance Private LimitedActive 23 years 1 monthJayesh Naik and Vishal Naik are mutual person
- Krishna Builders And Developers Private LimitedActive 13 years 2 months
Jayesh Naik and Vishal Naik are mutual person
- Sunny Fragrance Private LimitedActive 23 years 9 months
Jayesh Naik and Vishal Naik are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhanish Pharma Distributors?
Unlock and access historical data on people associated with Dhanish Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanish Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanish Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
